Sign In
Buy INO
$0.677
+0.0210 (+3.20%)
At Close: Jul 31, 2026
9 Stocks to Buy This Week as the Coronavirus Worsens
02:58pm, Wednesday, 22'nd Jul 2020
With the pandemic rearing its ugly head again, these nine companies should give you significant growth potential.
9 Stocks to Buy for the Second Coronavirus Wave
10:58am, Wednesday, 22'nd Jul 2020
With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy this week to capitalize on this trend.
Kamada: Under-The-Radar COVID-19 Therapy Play With Downside Protection And Margin Of Safety
10:51am, Wednesday, 22'nd Jul 2020
US and global pharma companies that are working on credible COVID-19 treatments are up massively YTD, often more than 100% and far surpassing performance of general pharma indices.
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
09:16am, Wednesday, 22'nd Jul 2020
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
The Curtain Is Coming Down on Inovio Pharmaceuticals’ Vaccine Candidate
08:27am, Wednesday, 22'nd Jul 2020
As multiple companies advance vaccine candidates into late-stage clinical trials, INO stock is losing momentum. Is this the end or just a pause?
4 Catalysts Could Drive Inovio Pharmaceuticals Stock to Near-term Highs
05:16am, Wednesday, 22'nd Jul 2020
Inovio Pharmaceuticals remains one of the most undervalued of the vaccine makers. Even after a 455% run higher, INO stock has plenty of upside fueled by plenty of catalysts.
2020 Insights into the Cancer Vaccines Market - Pipeline Analysis Report - ResearchAndMarkets.com
12:00am, Wednesday, 22'nd Jul 2020
The
Democratic lawmakers signal concern about coronavirus vaccine pricing, speed of development
08:48pm, Tuesday, 21'st Jul 2020
Lawmakers peppered pharmaceutical executives with questions about how COVID-19 vaccines will be manufactured, priced and distributed, the day after promising...
Investors cheer as two coronavirus vaccine candidates report T-cell responses, but findings are still early stage
10:25am, Tuesday, 21'st Jul 2020
At least two experimental COVID-19 vaccines produced a T-cell response in participants in early-stage clinical trials, which may indicate a more durable form...
Inovio May Be Losing the Covid-19 Vaccine Race
06:19pm, Monday, 20'th Jul 2020
Moderna and AstraZeneca both are making rapid progress on their coronavirus vaccines. For Inovio, this means that the clock is ticking down.
Inovio May Be Losing the Covid-19 Vaccine Race
02:19pm, Monday, 20'th Jul 2020
Moderna and AstraZeneca both are making rapid progress on their coronavirus vaccines. For Inovio, this means that the clock is ticking down.
IBio's stock soars, but Novavax and Inovio stocks fall amid news on other COVID-19 vaccine candidates
02:17pm, Monday, 20'th Jul 2020
Shares of companies with COVID-19 vaccine candidates were mixed in volatile trading Monday, after the promising results from trials of vaccine candidates...
Inovio Pharmaceuticals (INO) Receives a Hold from H.C. Wainwright - Markets
10:22am, Monday, 20'th Jul 2020
In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Hold rating on Inovio Pharmaceuticals (INO – Research
IBio's stock soars, but Novavax and Inovio stocks fall amid news on other COVID-19 vaccine candidates
10:17am, Monday, 20'th Jul 2020
Shares of companies with COVID-19 vaccine candidates were mixed in volatile trading Monday, after the promising results from trials of vaccine candidates from Pfizer Inc.
‘A Powerful Force’: Tesla’s Momentum Leads Stock-Market Surge
05:38pm, Sunday, 19'th Jul 2020
Some momentum stocks, like Tesla, have yet to record a full-year profit, but their future potential and recent stock performance have still attracted hordes of buyers.
